Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
114 EUR | +0.13% | -.--% | -.--% |
Apr. 11 | U.S. Futures Down, European Stocks Mixed | DJ |
Apr. 08 | DSM-Firmenich AG announces an Equity Buyback for 1,500,000 shares, representing 0.6% of its issued share capital. | CI |
Sales 2024 * | 12.69B 13.61B | Sales 2025 * | 13.34B 14.31B | Capitalization | 27.59B 29.59B |
---|---|---|---|---|---|
Net income 2024 * | 477M 512M | Net income 2025 * | 785M 842M | EV / Sales 2024 * | 2.41 x |
Net Debt 2024 * | 2.97B 3.19B | Net Debt 2025 * | 2.68B 2.87B | EV / Sales 2025 * | 2.27 x |
P/E ratio 2024 * |
58.1
x | P/E ratio 2025 * |
34.6
x | Employees | 28,685 |
Yield 2024 * |
2.36% | Yield 2025 * |
2.38% | Free-Float | 25.03% |
Latest transcript on Koninklijke DSM
1 day | +0.13% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 89-12-31 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 23-08-31 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 23-01-31 | |
Thomas Leysen
CHM | Chairman | 63 | 23-01-31 |
Director/Board Member | 62 | 23-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.43% | 303 M€ | +11.58% | ||
1.13% | 18 M€ | +3.04% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.05% | 878B | |
0.00% | 239B | |
+24.73% | 174B | |
-7.11% | 127B | |
+30.14% | 81.93B | |
-3.89% | 75.21B | |
-15.83% | 50.92B | |
-24.26% | 39.43B | |
+19.91% | 33.5B |
- Stock Market
- Equities
- DSFIR Stock
- DSM Stock